我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

阿司匹林抵抗产生机制的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第5期
页码:
638-640
栏目:
综述
出版日期:
2008-10-20

文章信息/Info

Title:
-
作者:
李佳蓓 综述黄岚 审校
重庆市第三军医大学附属新桥医院全军心血管内科研究所,重庆 400037
Author(s):
-
关键词:
阿司匹林抵抗血小板功能检测基因多态性
Keywords:
-
分类号:
R971.1
DOI:
-
文献标识码:
A
摘要:
抗血小板药物阿司匹林广泛运用于心血管疾病的一级和二级预防中。临床上服用阿司匹林治疗的患者对该药物的反应性差异很大,有的患者的反应性很差甚至无反应,称之为阿司匹林抵抗。导致阿司匹林抵抗的机制,包括依从性差、药物间的相互作用和剂量不足等。通过进一步研究阿司匹林抵抗的机制,有助于优化抗血小板治疗。
Abstract:
-

参考文献/References

[1] 谭真,黄德嘉,张敏,等. 美洛昔康与小剂量阿司匹林联用对心血管病患者前列环素-血栓烷A2平衡的影响[J]. 心脏杂志, 2005, 17(4):376-379,382.
[2] Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?[J]. Am Heart J, 2004, 147 (2):293-300.
[3] Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation[J]. J Am Coll Cardiol, 2005, 46(9):1705-1709.
[4] Lee PY, Chen WH, Ng W, et al. Lowdose aspirin increases aspirin resistance in patients with coronary artery disease[J]. Am J Med, 2005, 118(7):723-727.
[5] Cox D, Maree AO, Dooley M, et al. Effect of enteric coating on antiplatelet activity of lowdose aspirin in healthy volunteers[J]. Stroke, 2006, 37(8):2153-2158.
[6] Karha J, Rajagopal V, KottkeMarchant K, et al. Lack of effect of enteric coating on aspirininduced inhibition of platelet aggregation in healthy volunteers[J]. Am Heart J, 2006, 151(5):976.e7-976.e11.
[7] Capone ML, Sciulli MG, Tacconelli S, et al. Pharmacodynamic interaction of naproxen with lowdose aspirin in healthy subjects [J]. J Am Coll Cardiol, 2005, 45(8):1295-1301.
[8] Poulsen TS, Mickley H. Is the antiplatelet effect of aspirin affected by systemic inflammation?[J]. Ann Hematol, 2004, 83(11):728.
[9] Jefferson BK, Foster JH, McCarthy JJ, et al. Aspirin resistance and a single gene[J]. Am J Cardiol, 2005, 95(6):805-808.
[10]Fontana P, Nolli S, Reber G, et al. Biological effects of aspirin and clopidogrel in a randomized crossover study in 96 healthy volunteers[J]. J Thromb Haemost, 2006, 4(4):813-819.
[11]Frelinger AL 3rd, Furman MI, Linden MD, et al. Residual arachidonic acidinduced platelet activation via an adenosine diphosphatedependent but cyclooxygenase1and cyclooxygenase2independent pathway: a 700patient study of aspirin resistance[J]. Circulation, 2006, 113(25):2888-2896.
[12]Pulcinelli FM, Riondino S, Celestini A, et al. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin[J]. J Thromb Haemost, 2005, 3(12):2784-2789.

备注/Memo

备注/Memo:
收稿日期:2008-01-11.通讯作者:黄岚,主任医师,主要从事冠状动脉粥样硬化及冠 心病防治研究Email:huanglan260@yahoo.com.cn 作者简介:李佳蓓,硕士生Email:jblee918@yahoo.com
更新日期/Last Update: